Medicine composition for inhibiting ovarian carcinoma cells
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZUNYI MEDICAL UNIVERSITY
- Publication Date
- 2019-03-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biomedicine, in particular to a pharmaceutical composition for inhibiting ovarian cancer cells. Background technique
[0002] Cancer is a major disease that seriously threatens human survival and social development. Among them, ovarian cancer (ovarian carcinoma) is one of the three most common malignant tumors in women, and its incidence rate ranks third, after breast cancer and cervical cancer. However, because the ovary is located in the deep part of the pelvic cavity, early lesions are not easy to be found. Once symptoms appear, most of them are late. Therefore, its mortality rate ranks first in gynecological tumors.
[0003] The current clinical treatment of ovarian cancer is a combination of surgery and chemotherapy. Chemotherapy can be used alone in the palliative treatment of advanced cancer, or as a part of comprehensive treatment, combined with surgery, radiotherapy, etc. Chemotherapy can preve...